公司名称: |
国药集团化学试剂有限公司 |
联系电话: |
86-21-63210123 |
产品介绍: |
英文名称:Phensuximide (500 mg) CAS:86-34-0 包装信息:500 mg 备注:品牌:USP产品编号:U1528002 |
公司名称: |
武汉泰凯塞科技有限公司 |
联系电话: |
027-51830495 13986148687 |
产品介绍: |
CAS:86-34-0 纯度:98% HPLC 包装信息:5g,10g,25g,100g,1kg |
公司名称: |
北京华美互利生物化工 |
联系电话: |
010-56205725 |
产品介绍: |
英文名称:PhensuxiMide CAS:86-34-0 纯度:99% 包装信息:25kg |
公司名称: |
上海陶素生化科技有限公司 |
联系电话: |
021-33632979 |
产品介绍: |
英文名称:PHENSUCCIMIDE CAS:86-34-0 纯度:90% 包装信息:50Mg 备注:仅供科研使用 |
公司名称: |
江苏艾康生物医药研发有限公司 |
联系电话: |
025-66099280 17798518460 |
产品介绍: |
CAS:86-34-0 纯度:95+% 包装信息:1g;5g;10g |
|
中文名称: | 密朗丁 | 中文同义词: | 1-甲基-3-苯基吡咯烷-2,5-二酮;苯琥胺;米浪丁;密朗丁;1-甲基-3-苯基-2,5-吡咯烷二酮;苯琥胺 USP标准品;化合物 T25945 | 英文名称: | PHENSUXIMIDE | 英文同义词: | (.+/-.)-N-Methyl-2-phenylsuccinimide;1-Methyl-3-phenyl-2,5-pyrrolidinedione;1-methyl-3-phenyl-5-pyrrolidinedione;1-Methyl-3-phenylpyrrolidin-2,5-dione;1-methyl-3-phenyl-pyrrolidine-2,5-quinone;Phensuximide (500 mg);PHENSUCCIMIDE;1-Methyl-3-Phenylsuccinimide | CAS号: | 86-34-0 | 分子式: | C11H11NO2 | 分子量: | 189.21 | EINECS号: | 201-664-6 | 相关类别: | MILONTIN | Mol文件: | 86-34-0.mol |  |
熔点 | 71-73° | 沸点 | 324.47°C (rough estimate) | 密度 | 1.1596 (rough estimate) | 折射率 | 1.5012 (estimate) | 储存条件 | Refrigerator | 溶解度 | Chloroform (Slightly), Ethyl Acetate (Slightly) | 形态 | Solid | 酸度系数(pKa) | -1.86±0.40(Predicted) | 颜色 | White to Off-White | 水溶解性 | 4.2g/L(25 ºC) |
生物活性 | Phensuximide 是一种琥珀酰亚胺类抗癫痫 (antiepileptic) 和抗惊厥 (anticonvulsant) 试剂。Phensuximide 可以抑制去极化脑组织中 cyclic AMP 和 cyclic GMP 的积累。在动物模型中,Phensuximide 可用于癫痫研究的相关研究。 | 靶点 |
IC50: cyclic AMP and cyclic GMP accumulation
| 体外研究 |
Phensuximide produce depolarization-induced accumulation of cyclic GMP or cyclic AMP levels with ID
50
values of 8.00 mM or 6.20 mM in incubated slices of mouse cerebral cortex.Phensuximide (0.5-2.0 mM) has the ability to competitively inhibit mephenytoin 4-hydroxylase activity in human liver microsomes, the K
i
and K
m
values are 559 μM and 235 μM, respectively.
| 体内研究 |
Phensuximide (intraperitoneal injection; 1.25 mmol/kg; single dose) induces mild changes in renal function, including: trace hematuria, increased proteinuria and decreased paminohippurate uptake in Sprague-Dawley rats.Phensuximide (intraperitoneal injection; 0.3 or 0.6 mmol/kg; 5-7 days) results in transient hematuria and proteinuria, but no change in the other renal function parameters studied. It is concluded that phensuximide produces mild, transient renal effects in Fischer 344 rats, and that the Fischer 344 rat is a suitable model for studying phensuximide-induced toxicity to the urinary tract.
Animal Model:
|
Fischer 344 rats
|
Dosage:
|
0.3 or 0.6 mmol/kg
|
Administration:
|
Intraperitoneal injection; 5-7 days
|
Result:
|
Induced urotoxicity following daily administration for 5-7 days in Fischer 344 rats.
|
|
海关编码 | 2925190100 | 毒性 | LD50 orally in mice: 960 mg/kg (Chen, Ensor) |
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 | 2022/07/01 | HY-B1730 | 密朗丁 Phensuximide | 86-34-0 | 10mg | 1100元 | | 2022/07/01 | HY-B1730 | 密朗丁 Phensuximide | 86-34-0 | 10mM * 1mLin DMSO | 1210元 | |
|